Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1982 Aug;70(2):361–368. doi: 10.1172/JCI110625

Thromboxane Mediation of Cardiopulmonary Effects of Embolism

Takayoshi Utsunomiya 1,2,3,4, Michael M Krausz 1,2,3,4, Lawrence Levine 1,2,3,4, David Shepro 1,2,3,4, Herbert B Hechtman 1,2,3,4
PMCID: PMC371244  PMID: 6284801

Abstract

Humoral factors released from platelets during pulmonary embolism may be the cause of several attendant cardiopulmonary abnormalities. This study examines the role of thromboxanes (Tx) after experimental embolism induced with 0.5 g/kg autologous clot in four groups of five dogs: (a) untreated embolized controls; (b) pretreatment with the Tx synthetase inhibitor, imidazole 25 mg/kg · h i.v., starting 30 min before embolization; (c) pretreatment with the cyclooxygenase inhibitor indomethacin, 5 mg/kg, 12 h per os and 1 mg/kg, 1 h i.v. before the experiment; (d) treatment with prostacyclin (PGI2) 100 ηg/kg · min i.v. for 1 h, 1 h after embolization. Within 30 min, embolization led to increases of 6-keto-PGF1α, the stable hydrolysis product of PGI2, from 0.11±0.08 ηg/ml (mean±SD) to 0.33±0.10 ηg/ml (P < 0.005) and TxB2, the stable product of TxA2, from 0.10±0.04 ηg/ml to 0.38±0.06 ηg/ml (P < 0.001). Increases were observed in total dead space (VD/VT) from 0.46±0.03 to 0.61±0.08 (P < 0.025, physiologic shunting (Q̇S/Q̇T) from 16±4% to 38±9% (P < 0.01), pulmonary vascular resistance (PVR) from 2.27±0.59 mm Hg·min/liter to 9.21±1.90 mm Hg·min/liter (P < 0.005) and mean pulmonary arterial pressure from 14±6 mm Hg to 34±1 mm Hg (P < 0.001). Cardiac index (CI) fell from 139±11 ml/kg·min to 95±17 ml/kg·min in 4 h (P < 0.025). Imidazole pretreatment prevented a rise of TxB2, but not 6-keto-PGF1α; indomethacin blocked both. Both agents maintained VD/VT at base line and limited increases in Q̇S/Q̇T and PVR. CI was higher after imidazole pretreatment compared with controls (P < 0.025). Indomethacin led to intermediate levels of CI. PGI2 lowered TxB2 (P < 0.025), VD/VT (P < 0.025), Q̇S/Q̇T (P < 0.025) and PVR (P < 0.05) within 30 min. During PGI2 infusion, CI was higher than controls. Concentrations of TxB2 correlated with VD/VT, r = 0.79 and Q̇S/Q̇T, r = 0.69 (P < 0.001). Treatment of three dogs with the imidazole derivative ketoconazole, 10 mg/kg IV, 30 min after 0.75 g/kg autologous clot resulted in a lowering of physiologic dead space, but no other improvement of cardiopulmonary function. These results show that a number of cardiopulmonary abnormalities induced by pulmonary embolism are related directly or indirectly to platelet secretions and that VD/VT is closely allied to TxA2 levels.

Full text

PDF
361

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alam I., Ohuchi K., Levine L. Determination of cyclooxygenase products and prostaglandin metabolites using high-pressure liquid chromatography and radioimmunoassay. Anal Biochem. 1979 Mar;93(2):339–345. doi: 10.1016/s0003-2697(79)80160-8. [DOI] [PubMed] [Google Scholar]
  2. Dawson W., Boot J. R., Cockerill A. F., Mallen D. N., Osborne D. J. Release of novel prostaglandins and thromboxanes after immunological challenge of guinea pig lung. Nature. 1976 Aug 19;262(5570):699–702. doi: 10.1038/262699a0. [DOI] [PubMed] [Google Scholar]
  3. Dunham B. M., Grindlinger G. A., Utsunomiya T., Krausz M. M., Hechtman H. B., Shepro D. Role of prostaglandins in positive end-expiratory pressure-induced negative inotropism. Am J Physiol. 1981 Dec;241(6):H783–H788. doi: 10.1152/ajpheart.1981.241.6.H783. [DOI] [PubMed] [Google Scholar]
  4. Elkins R. C., Lane M., Greenfield L. J. Pulmonary vascular response to experimental embolism and reversal by embolectomy. J Surg Res. 1978 Aug;25(2):135–142. doi: 10.1016/0022-4804(78)90067-7. [DOI] [PubMed] [Google Scholar]
  5. Gaudet R. J., Alam I., Levine L. Accumulation of cyclooxygenase products of arachidonic acid metabolism in gerbil brain during reperfusion after bilateral common carotid artery occlusion. J Neurochem. 1980 Sep;35(3):653–658. doi: 10.1111/j.1471-4159.1980.tb03704.x. [DOI] [PubMed] [Google Scholar]
  6. Greenwald J. E., Wong L. K., Rao M., Bianchine J. R., Panganamala R. V. A study of three vasodilating agents as selective inhibitors of thromboxane A2 biosynthesis. Biochem Biophys Res Commun. 1978 Oct 30;84(4):1112–1118. doi: 10.1016/0006-291x(78)91698-4. [DOI] [PubMed] [Google Scholar]
  7. HALMAGYI D. F., STARZECKI B., HORNER G. J. HUMORAL TRANSMISSION OF CARDIORESPIRATORY CHANGES IN EXPERIMENTAL LUNG EMBOLISM. Circ Res. 1964 Jun;14:546–554. doi: 10.1161/01.res.14.6.546. [DOI] [PubMed] [Google Scholar]
  8. Hechtman H. B., Lonergan E. A., Shepro D. Platelet and leukocyte lung interactions in patients with respiratory failure. Surgery. 1978 Feb;83(2):155–163. [PubMed] [Google Scholar]
  9. Hechtman H. B., Lonergan E. A., Staunton H. P., Dennis R. C., Shepro D. Pulmonary entrapment of platelets during acute respiratory failure. Surgery. 1978 Mar;83(3):277–283. [PubMed] [Google Scholar]
  10. Hechtman H. B., Reid M. H., Dorn B. C., Weisel R. D. Indicator dilution measurements of lung volumes and alveolar air exchange during breathing. J Clin Invest. 1973 May;52(5):1215–1229. doi: 10.1172/JCI107289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Levine L., Alam I., Langone J. J. The use of immobilized ligands and [125I]protein a for immunoassays of thromboxane B2, prostaglandin D2, 13,14-dihydro-prostaglandin E2, 5,6-dihydro-prostaglandin I2, 6-keto-prostaglandin F1 alpha, 15-hydroxy-9 alpha, 11 alpha(epoxymethano)prosta-5,13-dienoic acid and 15-hydroxy-11 alpha,9 alpha(epoxymethano)prosta-5,13-dienoic acid. Prostaglandins Med. 1979 Mar;2(3):177–189. doi: 10.1016/0161-4630(79)90035-1. [DOI] [PubMed] [Google Scholar]
  12. Moncada S., Amezcua J. L. Prostacyclin, thromboxane A2 interactions in haemostasis and thrombosis. Haemostasis. 1979;8(3-5):252–265. doi: 10.1159/000214316. [DOI] [PubMed] [Google Scholar]
  13. Moncada S., Vane J. R. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N Engl J Med. 1979 May 17;300(20):1142–1147. doi: 10.1056/NEJM197905173002006. [DOI] [PubMed] [Google Scholar]
  14. Rosoff C. B., Salzman E. W., Gurewich V. Reduction of platelet serotonin and the response to pulmonary emboli. Surgery. 1971 Jul;70(1):12–19. [PubMed] [Google Scholar]
  15. Schulman E. S., Newball H. H., Demers L. M., Fitzpatrick F. A., Adkinson N. F., Jr Anaphylactic release of thromboxane A2, prostaglandin D2, and prostacyclin from human lung parenchyma. Am Rev Respir Dis. 1981 Oct;124(4):402–406. doi: 10.1164/arrd.1981.124.4.402. [DOI] [PubMed] [Google Scholar]
  16. Spannhake E. W., Levin J. L., Mellion B. T., Gruetter C. A., Hyman A. L., Kadowitz P. J. Reversal of 5HT-induced bronchoconstriction by PGI2: distribution of central and peripheral actions. J Appl Physiol Respir Environ Exerc Physiol. 1980 Sep;49(3):521–527. doi: 10.1152/jappl.1980.49.3.521. [DOI] [PubMed] [Google Scholar]
  17. Utsunomiya T., Krausz M. M., Dunham B., Mannick J. A., Allen P. D., Shepro D., Hechtman H. B. Maintenance of cardiodynamics with aspirin during abdominal aortic aneurysmectomy (AAA). Ann Surg. 1981 Nov;194(5):602–608. doi: 10.1097/00000658-198111000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Utsunomiya T., Krausz M. M., Shepro D., Hechtman H. B. Prostaglandin control of plasma and platelet 5-hydroxytryptamine in normal and embolized animals. Am J Physiol. 1981 Nov;241(5):H766–H771. doi: 10.1152/ajpheart.1981.241.5.H766. [DOI] [PubMed] [Google Scholar]
  19. Utsunomiya T., Krausz M. M., Valeri C. R., Levine L., Shepro D., Hechtman H. B. Treatment of pulmonary embolism with positive end-expiratory pressure and prostaglandin E1. Surg Gynecol Obstet. 1981 Aug;153(2):161–168. [PubMed] [Google Scholar]
  20. Utsunomiya T., Krausz M. M., Valeri C. R., Shepro D., Hechtman H. B. Treatment of pulmonary embolism with prostacyclin. Surgery. 1980 Jul;88(1):25–30. [PubMed] [Google Scholar]
  21. Vaage J., Gjesdal K. Lung responses and platelet release reaction following induced intravascular platelet aggregation in the cat. Scand J Clin Lab Invest. 1976 Nov;36(7):641–648. doi: 10.1080/00365517609054489. [DOI] [PubMed] [Google Scholar]
  22. Vaage J., Hauge A. Small airway constriction and closure after induced intravascular platelet aggregation. Acta Physiol Scand. 1977 Jun;100(2):221–230. doi: 10.1111/j.1748-1716.1977.tb05940.x. [DOI] [PubMed] [Google Scholar]
  23. Vargaftig B. B., Lefort J., Joseph D., Fouque F. Mechanisms of bronchoconstriction and of thrombocytopenia induced by collagen in the guinea pig. Eur J Pharmacol. 1979 Oct 1;58(3):273–284. doi: 10.1016/0014-2999(79)90476-x. [DOI] [PubMed] [Google Scholar]
  24. Woolverton W. C., Hyman A. L. The pulmonary hemodynamic effects of lung thromboemboli in dogs. Surgery. 1973 Apr;73(4):572–578. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES